Skip to content

4Accepted Sep 5, 4:15 PM ET

Arbet-Engels Christophe 4

XFORX4 Pharmaceuticals, Inc

Accepted (ET)

4:15 PM

Sep 5, 2023

Filed

Sep 5, 2023

Documents

1

Size

5.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.